Miromatrix Medical Inc. (MIRO): Price and Financial Metrics
GET POWR RATINGS... FREE!
MIRO Stock Price Chart Interactive Chart >
MIRO Price/Volume Stats
| Current price | $4.00 | 52-week high | $16.52 |
| Prev. close | $3.77 | 52-week low | $2.02 |
| Day low | $3.86 | Volume | 4,900 |
| Day high | $4.00 | Avg. volume | 83,387 |
| 50-day MA | $3.71 | Dividend yield | N/A |
| 200-day MA | $5.66 | Market Cap | 82.27M |
Miromatrix Medical Inc. (MIRO) Company Bio
Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company also develops organ-derived biological products for various applications, such as soft tissue reinforcement and wound care. It uses its perfusion decellularization/recellularization technology to engineer transplantable organs for the people who need them. Miromatrix Medical Inc. has strategical partnerships with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. Miromatrix Medical Inc. was formerly known as TayTech, Inc. The company was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Latest MIRO News From Around the Web
Below are the latest news stories about Miromatrix Medical Inc that investors may wish to consider to help them evaluate MIRO as an investment opportunity.
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will ring the closing bell at Nasdaq on Monday, February 14, 2022, at 4:00 p.m. ET to celebrate National Donor Day and the Company’s public listing last year on Nasdaq under the trading symbol MIRO. Miromatrix CEO, Jeff Ross, Ph.D., wi |
Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceEDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Miromatrix Medical's management is scheduled to present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Thursday, F |
Miromatrix adds Lisa Wipperman Heine, William Burke to boardThe company's goal is to scale its organ engineering technology in order to address the shortage of available human organs. |
Miromatrix Announces Two New Board MembersEDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appointment of two new board members: Lisa Wipperman Heine and William P. Burke. "I am thrilled to welcome Lisa and Bill to the Miromatrix Board as we continue developing bioengineered organs to address the transpla |
Miromatrix Medical Inc.s Lock-Up Period Set To End Tomorrow (NASDAQ:MIRO)Miromatrix Medicals (NASDAQ:MIRO) lock-up period is set to end on Tuesday, December 21st. Miromatrix Medical had issued 4,800,000 shares in its IPO on June 24th. The total size of the offering was $43,200,000 based on an initial share price of $9.00. After the expiration of Miromatrix Medicals lock-up period, restrictions preventing company insiders and major [] The post Miromatrix Medical Inc.s Lock-Up Period Set To End Tomorrow (NASDAQ:MIRO) appeared first on ETF Daily News . |
MIRO Price Returns
| 1-mo | 11.11% |
| 3-mo | 2.56% |
| 6-mo | -38.08% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -14.71% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...